Nplate (romiplostim) is a weekly subcutaneous thrombopoietin receptor agonist for immune thrombocytopenia, supplied as a lyophilised powder in single-dose vials stored in a refrigerator.
M Care Exports supplies hospitals, licensed importers, distributors and tender authorities internationally, with established supply lanes into the GCC, Africa and Europe, and quotes Nplate (romiplostim) from Amgen alongside Indian-made romiplostim lines. If you are looking for Nplate 250 mcg or the 125 mcg and 500 mcg vials, send the destination, strength and quantity, and we quote per destination, subject to each destination's registration route and import licence.
Romiplostim exporter and bulk supplier from India.
"We need a partner for Nplate 250 mcg for a haematology unit" is a typical enquiry. M Care is a merchant-exporter: we quote against your specification and confirm which presentation your destination accepts. The US label lists romiplostim as a lyophilised powder in single-dose vials of 125 mcg, 250 mcg and 500 mcg. The UK emc SmPC for the 250 mcg product describes a pack with a vial, a pre-filled syringe of water for injections, a plunger rod, a vial adapter, a syringe, a safety needle and alcohol swabs, supplied as a single pack or a multipack of 4, and notes that not all pack sizes may be marketed. Packs differ by market, so the quote turns on the pack you need, the quantity, cold-chain packing, the destination's registration route and Incoterms. M Care supplies both originator or regulator-registered brands and Indian-made lines. Our own catalogue lists an Indian-made Romiplostim 250mcg line (Romy Injection) for destinations whose registration accepts it. We make no claim that it is registered in any particular destination.
Source
WHO-GMP-certified Indian manufacturing line, named on every quote.
Minimum order
No blanket MOQ. Set by the source manufacturer's minimum batch-release quantity for the strength and pack ordered.
Pricing
On request. Indicative FOB or CIF quote, formal proforma on confirmation.
Incoterms
EXW, FOB, CIF, CIP or DAP.
Payment
Letter of credit (sight or usance) and telegraphic transfer.
Documentation
WHO-GMP certificate of the source line, product-specific CoPP, batch CoA, method of analysis, Free Sale Certificate, Certificate of Origin, CTD or eCTD dossier. On request.
Shelf-life
Minimum remaining shelf-life agreed per order and confirmed on the proforma.
Response
Availability and CoPP status within two working days; pre-alert documents before dispatch.
Thrombopoietin receptor agonist, sourced and documented for export.
Romiplostim is the active substance in Nplate, marketed by Amgen. The US label (DailyMed, Amgen Inc., prescribing information revised 3/2025) lists it for thrombocytopenia in adults with ITP that had an insufficient response to corticosteroids, immunoglobulins or splenectomy, for paediatric patients aged 1 year and older with ITP for at least 6 months and the same insufficient response, and for increasing survival in adults and paediatric patients acutely exposed to myelosuppressive doses of radiation (Hematopoietic Syndrome of Acute Radiation Syndrome). The label states it is not indicated for thrombocytopenia due to myelodysplastic syndrome or any cause other than ITP. The EMA page lists Amgen Europe B.V. as marketing authorisation holder, with the marketing authorisation issued on 4 February 2009, for primary ITP in adults refractory to other treatments, and for chronic primary ITP in paediatric patients aged 1 year and older refractory to other treatments. In the UK, the emc SmPC for Nplate 250 micrograms names Amgen Limited as marketing authorisation holder and lists the adult primary ITP indication, and the emc SmPC for Nplate 125 micrograms also lists chronic primary ITP in paediatric patients aged one year and older.
Active ingredient
Romiplostim. Thrombopoietin receptor agonist.
Forms and strengths
125 mcg lyophilised powder single-dose vial; 250 mcg lyophilised powder single-dose vial; 500 mcg lyophilised powder single-dose vial.
Indications
Romiplostim (Nplate, Amgen) is a weekly subcutaneous treatment for immune thrombocytopenia, with a further US-labelled indication for acute radiation syndrome, supplied as a refrigerated lyophilised powder in single-dose vials.
Administration
Subcutaneous. Lyophilised powder for solution for injection in single-dose vials.
Documentation
Batch-specific CoA, CoPP, manufacturing-site WHO-GMP certificate and stability data compiled per consignment, in the format the destination regulator expects.
Hospital pharmacies, licensed importers and tender desks across our export markets.
India is our origin. We do not sell into the Indian market.
Buyers are hospital pharmacists and haematology units, MoH and hospital tender desks, and licensed importers and distributors internationally. Typical enquiries read "I'm looking for Nplate 250 mcg for a haematology unit" or "We need a partner for romiplostim vials for a tender". Each destination has its own route to registration or import, for example the Emirates Drug Establishment (EDE) in the UAE, NAFDAC in Nigeria and the MHRA in the UK, and we align the offer with it before quoting. For a refrigerated biologic, whether the destination has registered the product or needs a named-patient or unlicensed import depends on the regulator, and M Care Exports confirms the route per enquiry. We supply both originator or regulator-registered brands and Indian-made lines.
GCC registration routes
Supply against MoH registration held by your local licensed importer, or via the GCC central registration pathway.
UK unlicensed routes
Where no UK licence exists, the MHRA Specials and named-patient import routes cover clinically justified demand.
Tender desks
Bid-pack documentation assembled to the tender's specification, from CoPP to batch records.
Dossier support
CTD documentation from the sourcing manufacturer, compiled for your regulator's format.
What the dispensing pharmacist checks on romiplostim.
Treat Nplate as a weight-based, titrated weekly dose, not a fixed vial. The US label starts ITP at 1 mcg/kg once weekly using actual body weight, adjusts in 1 mcg/kg steps and does not exceed 10 mcg/kg weekly. It raises the dose if platelets are below 50 x 10^9/L, lowers it if they are above 200 x 10^9/L and at or below 400 x 10^9/L for 2 consecutive weeks, and withholds it above 400 x 10^9/L. The UK 250 mcg SmPC states different default thresholds (reduction above 150 x 10^9/L for two consecutive weeks, withholding above 250 x 10^9/L) and says higher cut-offs of 200 and 400 x 10^9/L may be considered according to medical judgement, so follow the label of your destination. The US label says to reconstitute with Sterile Water for Injection, not with bacteriostatic water, and not to dilute with bacteriostatic sodium chloride; both labels say do not shake. The US label requires a syringe with 0.01 mL graduations and says calculated doses under 23 mcg need further dilution with 0.9% Sodium Chloride Injection. The UK SmPC notes that medication errors including overdose and underdose have been reported. The US label's Warnings and Precautions include progression of myelodysplastic syndromes to acute myelogenous leukaemia and thrombotic/thromboembolic complications. Store at 2 to 8 degrees C in the original carton, protected from light, and do not freeze. Both labels allow room-temperature storage up to 25 degrees C for up to 30 days, and the US label says the vial must not go back into the refrigerator afterwards.
The documentation pack a regulator actually asks for.
Nplate is a cold-chain biologic. The US label and the UK SmPC both require storage at 2 to 8 degrees C in the original carton without freezing. Both allow room-temperature storage up to 25 degrees C for up to 30 days, and the US label says to write the new expiry date on the carton and not to return the vial to the refrigerator. Export consignments are packed with qualified insulated shippers and temperature loggers, timed to the receiving site. M Care documentation covers batch certificates of analysis, export documents and destination-aligned dossier support where the regulator asks for it. We state the source and status of each line before quoting. For the Indian-made line in our catalogue we do not claim registration in any destination, and we make no manufacturing or WHO claim for M Care itself, which is a merchant-exporter.
CoA and MoA, per batch
Batch-specific certificate and method of analysis from the sourcing manufacturer's QC release.
CoPP, WHO-GMP, MFG licence
Certificate of pharmaceutical product, site GMP certificate and manufacturing licence, issued by the state drug regulator and naming the actual manufacturing site.
CTD Module 3
Chemistry, manufacturing and controls documentation available from the sourcing manufacturer for registration filings.
Pack insert, labels, artwork
Destination-language patient information and labelling to the local regulator's standard, locked before shipment.
Pharmacovigilance
A named PV contact arranged in the destination market where the registration requires one.
Adjacent lines procurement desks order alongside romiplostim.
Molecule · strength · volume · destination. One working day to a quote.
- Send us the specifics. Form and strength, pack preference, destination market and indicative volume for romiplostim.
- We route to the right line. The enquiry goes to the WHO-GMP certified manufacturing partner whose certificates fit your regulator.
- Commercial and regulatory offer. FOB or CIF price with the documentation list, named manufacturing site and current certificate validity.
- Order, produce, release, ship. QC release on the Indian side, batch documents compiled, despatch on the agreed incoterm.
- After delivery. Batch records and certificates archived and retrievable for the life of the product on your shelf.
Romiplostim supply, the specific questions.
What is the Nplate 250 price for an importer?
We do not publish prices. The landed price of Nplate 250 mcg depends on whether you want the Amgen originator or an Indian-made romiplostim line, the strength (125, 250 or 500 mcg), the pack, the quantity, the registration route in your destination, cold-chain freight and Incoterms. Nplate is a refrigerated biologic, so insulated packing and temperature monitoring are part of the quote. M Care Exports quotes per destination once you send the strength, volume and country.
What sets the cost of Nplate injection for a hospital tender?
Cost for a tender is built from the same factors as any biologic: originator or Indian-made line, vial strength, pack format, annual quantity, the destination's registration or import-licence route, cold-chain handling and Incoterms. Because dosing is weight-based and adjusted weekly, state the vial strengths and the annual number of vials you need. We give no figure here. M Care Exports quotes per destination against your specification.
What is Nplate injection used for?
Nplate is labelled for immune thrombocytopenia (ITP). The US label covers adults with an insufficient response to corticosteroids, immunoglobulins or splenectomy, and paediatric patients aged 1 year and older with ITP for at least 6 months. It also lists increasing survival after acute exposure to myelosuppressive doses of radiation. The EMA page lists primary ITP in adults refractory to other treatments, and chronic primary ITP from age 1 year. The US label states it is not indicated for thrombocytopenia due to myelodysplastic syndrome or any cause other than ITP. Confirm the indications in your destination's approved text.
How is Nplate stored, and can vials leave the refrigerator?
Store at 2 to 8 degrees C in the original carton, protected from light, and do not freeze. The US label allows unopened vials at up to 25 degrees C for a single period of up to 30 days, with the new expiry date written on the carton and no return to the refrigerator. The UK SmPC for the 250 mcg pack allows up to 30 days at up to 25 degrees C in the original carton. Plan receiving-site cold storage before the shipment dispatches.
Is there a generic or biosimilar of Nplate?
The regulator pages we read (DailyMed, the EMA page and the UK emc SmPCs) do not show a generic or biosimilar of Nplate authorised in the US, EU or UK; each describes Amgen's Nplate. Our catalogue includes an Indian-made romiplostim line; we do not call it a generic or biosimilar or claim registration anywhere. Whether a destination accepts it depends on its regulator, and M Care Exports confirms this per enquiry.
How is Nplate dosed, and who can give it?
The US label gives ITP dosing as 1 mcg/kg once weekly subcutaneously, adjusted in 1 mcg/kg steps to a maximum of 10 mcg/kg weekly, based on platelet counts. The UK SmPC for the 250 mcg pack permits self-administration for adult patients with platelets stable at 50 x 10^9/L or above for at least 4 weeks without dose adjustment, at the discretion of the supervising physician and after training, and not for paediatric patients. The US Medication Guide describes it as given by your healthcare provider. Always follow your destination's label.
Who stands behind this page, and where its statements come from.
Reviewed by Dr. Rajat Bhatt, PharmD, Managing Director, M Care Exports. Last reviewed 2026-11-15.
This page is sourcing information for licensed importers, hospital procurement and tender desks. It is not medical, pharmaceutical or prescribing advice, and it is not a substitute for the approved product information of the line on your order. See our full disclaimer.
Send the specifics. You'll have a price inside one working day.
Form and strength, destination market and indicative volume. The Mumbai desk replies within one working day, including when the honest answer is that the route is not viable yet.
